GBZ
0.014
133.3%
ASR
0.001
-50%
SFG
0.002
100%
AN1
0.004
-33.3%
OLY
0.08
86%
ERA
0.002
-33.3%
OLH
0.025
56.3%
TEG
0.002
-33.3%
AUK
0.003
50%
ANX
0.005
-28.6%
OVT
0.003
50%
AMS
0.003
-25%
TMK
0.003
50%
WBE
0.003
-25%
CDE
0.048
41.2%
COY
0.011
-21.4%
SRL
0.91
40%
ADG
0.004
-20%
PGY
0.008
33.3%
AQC
0.044
-20%
SPQ
0.004
33.3%
BRU
0.024
-20%
AM5
0.009
28.6%
CUL
0.004
-20%
VAR
0.009
28.6%
EE1
0.004
-20%
RML
0.051
27.5%
MEM
0.004
-20%
LMG
0.01
25%
TON
0.004
-20%
OEL
0.005
25%
BEZ
0.047
-19%
SRJ
0.005
25%
CML
0.11
-18.5%
NH3
0.032
23.1%
HCL
0.27
-16.9%
IVG
0.033
22.2%
AZL
0.005
-16.7%
LOC
0.165
22.2%
NME
0.02
-16.7%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

CMP FDA clearance

Compumedics (ASX:CMP) announces the US FDA has cleared the Somfit device to be marketed in the USA. This marks the achievement of another significant strategic milestone for the Somfit technology platform in one of the world’s largest sleep markets https://www.compumedics.com.au/en/asx-announcements/somfit-update2-2/ #shorts